Enhancing tumor vaccines: catalyzing MHC class II peptide exchange

Expert Review of Vaccines
Nathan P Croft, Anthony W Purcell

Abstract

Peptide vaccination strategies aimed at inducing CD4(+) T-cell responses may be hampered due to the poorly receptive nature of MHC class II molecules to exogenous antigen. It has recently been reported that the small organic molecule adamantane ethanol, when included as an adjuvant in peptide vaccination, is capable of enhancing ligand exchange and markedly augmenting the subsequent antigen-specific CD4(+) T-cell response. These results highlight a novel adjuvant strategy tested in vivo, which opens a further doorway to improving the efficacy of peptide vaccination and continuing the push towards clinical trials.

References

Dec 10, 1998·Immunity·J D RabinowitzH M McConnell
Feb 27, 2003·Journal of Autoimmunity·Viviana Marin-EstebanOlaf Rötzschke
Sep 24, 2004·The Journal of Biological Chemistry·Viviana Marin-EstebanOlaf Rötzschke
Mar 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Melissa J NicholsonKai W Wucherpfennig
May 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Melissa J CallKai W Wucherpfennig
Jun 23, 2009·Nature·Koichi ArakiRafi Ahmed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.